Pfizer <PFE.N> rose 2.7% after the drugmaker raised full-year sales estimates for its COVID-19 vaccine, while Eli Lilly <LLY.N> slipped 4.6% on trimming its profit forecast.
Negative
Negative
Eli Lilly
Positive
Positive
Pfizer